日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Disease classification via interpretable machine learning based on multi-center routine coagulation test

基于多中心常规凝血试验的可解释机器学习疾病分类

Dong, Feng; Zhang, Yaqiong; Chen, Weibu; Wang, Changmin; Zhang, Lei; Gao, Xiaoling; Zhang, Xiaoli; Jiang, Minghua; Xu, Guobin; Yang, Ruichuang; Hou, Yutong; Ma, Jiandang; Li, Chuanbao; Wu, Jun

A Single Nucleotide Mixture Enhances the Antitumor Activity of Molecular-Targeted Drugs Against Hepatocellular Carcinoma

单核苷酸混合物增强分子靶向药物对肝细胞癌的抗肿瘤活性

Da Mao, Meihong Xu, Qiyu Jiang, Huiwei Sun, Fang Sun, Ruichuang Yang, Yantao Chai, Xiaojuan Li, Boan Li, Yong Li

Cryptotanshinone specifically suppresses NLRP3 inflammasome activation and protects against inflammasome-mediated diseases

隐丹参酮特异性抑制 NLRP3 炎症小体活化并预防炎症小体介导的疾病

Hongbin Liu, Xiaoyan Zhan, Guang Xu, Zhilei Wang, Ruisheng Li, Yan Wang, Qin Qin, Wei Shi, Xiaorong Hou, Ruichuang Yang, Jian Wang, Xiaohe Xiao, Zhaofang Bai

Spatiotemporal and Functional Heterogeneity of Hematopoietic Stem Cell-Competent Hemogenic Endothelial Cells in Mouse Embryos

小鼠胚胎中造血干细胞活性内皮细胞的时空和功能异质性

Yun-Qiao Li, Yandong Gong, Siyuan Hou, Tao Huang, Haizhen Wang, Di Liu, Yanli Ni, Chaojie Wang, Junliang Wang, Jun Hou, Ruichuang Yang, Jing Yan, Guangyu Zhang, Bing Liu, Yu Lan

Hlf Expression Marks Early Emergence of Hematopoietic Stem Cell Precursors With Adult Repopulating Potential and Fate

Hlf表达标志着具有成体重建潜能和命运的造血干细胞前体细胞的早期出现

Wanbo Tang ,Jian He ,Tao Huang ,Zhijie Bai ,Chaojie Wang ,Haizhen Wang ,Ruichuang Yang ,Yanli Ni ,Jun Hou ,Junliang Wang ,Jie Zhou ,Yingpeng Yao ,Yandong Gong ,Siyuan Hou ,Bing Liu ,Yu Lan

Evodiamine Inhibits Gastric Cancer Cell Proliferation via PTEN-Mediated EGF/PI3K Signaling Pathway

吴茱萸碱通过PTEN介导的EGF/PI3K信号通路抑制胃癌细胞增殖

Ruichuang Yang, Jianxia Wen, Tao Yang, Chunmei Dai, Yanling Zhao

Icariside Ⅱ, a main compound in Epimedii Folium, induces idiosyncratic hepatotoxicity by enhancing NLRP3 inflammasome activation

淫羊藿苷Ⅱ是淫羊藿中的主要成分,通过增强 NLRP3 炎症小体活化而引起特异质性肝毒性

Zhilei Wang, Guang Xu, Hongbo Wang, Xiaoyan Zhan, Yuan Gao, Nian Chen, Ruisheng Li, Xueai Song, Yuming Guo, Ruichuang Yang, Ming Niu, Jiabo Wang, Youping Liu, Xiaohe Xiao, Zhaofang Bai

In silico identification of EP400 and TIA1 as critical transcription factors involved in human hepatocellular carcinoma relapse

计算机模拟鉴定EP400和TIA1是参与人类肝细胞癌复发的关键转录因子

Hong, Weiguo; Hu, Yan; Fan, Zhenping; Gao, Rong; Yang, Ruichuang; Bi, Jingfeng; Hou, Jun

Quantitative examination of the inhibitory activation of molecular targeting agents in hepatocellular carcinoma patient-derived cell invasion via a novel in vivo tumor model

通过新型体内肿瘤模型定量检查分子靶向药物对肝细胞癌患者来源细胞侵袭的抑制激活

Huiwei Sun, Fan Feng, Hui Xie, Xiaojuan Li, Qiyu Jiang, Yantao Chai, Zhijie Wang, Ruichuang Yang, Ruisheng Li, Jun Hou

Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells

新型 ADAM-17 抑制剂 ZLDI-8 增强索拉非尼对肝细胞癌细胞的体外和体内化疗作用

Yingshi Zhang, Dandan Li, Qiyu Jiang, Shuang Cao, Huiwei Sun, Yantao Chai, Xiaojuan Li, Tianshu Ren, Ruichuang Yang, Fan Feng, Bo-An Li, Qingchun Zhao